Charles Schwab’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-426,549
| Closed | -$4.78M | – | 3093 |
|
|
2017
Q3 | $4.78M | Sell |
426,549
-4,003
| -0.9% | -$44.8K | ﹤0.01% | 1895 |
|
|
2017
Q2 | $4.74M | Sell |
430,552
-63,900
| -13% | -$703K | ﹤0.01% | 1848 |
|
|
2017
Q1 | $4.85M | Sell |
494,452
-3,255
| -0.7% | -$31.9K | ﹤0.01% | 1779 |
|
|
2016
Q4 | $5.38M | Buy |
497,707
+10,887
| +2% | +$118K | 0.01% | 1695 |
|
|
2016
Q3 | $4.99M | Buy |
486,820
+9,186
| +2% | +$94.2K | 0.01% | 1656 |
|
|
2016
Q2 | $6.24M | Buy |
477,634
+13,245
| +3% | +$173K | 0.01% | 1416 |
|
|
2016
Q1 | $5.11M | Sell |
464,389
-46,961
| -9% | -$517K | 0.01% | 1501 |
|
|
2015
Q4 | $4.71M | Sell |
511,350
-23,881
| -4% | -$220K | 0.01% | 1560 |
|
|
2015
Q3 | $3.72M | Buy |
535,231
+40,791
| +8% | +$283K | 0.01% | 1660 |
|
|
2015
Q2 | $4.86M | Buy |
494,440
+61,107
| +14% | +$600K | 0.01% | 1556 |
|
|
2015
Q1 | $3.84M | Buy |
433,333
+72,064
| +20% | +$639K | 0.01% | 1688 |
|
|
2014
Q4 | $3.17M | Buy |
361,269
+161,480
| +81% | +$1.41M | ﹤0.01% | 1743 |
|
|
2014
Q3 | $1.38M | Buy |
199,789
+83,454
| +72% | +$575K | ﹤0.01% | 2159 |
|
|
2014
Q2 | $612K | Sell |
116,335
-800
| -0.7% | -$4.21K | ﹤0.01% | 2539 |
|
|
2014
Q1 | $533K | Buy |
117,135
+3,000
| +3% | +$13.7K | ﹤0.01% | 2563 |
|
|
2013
Q4 | $576K | Buy |
114,135
+3,600
| +3% | +$18.2K | ﹤0.01% | 2541 |
|
|
2013
Q3 | $563K | Sell |
110,535
-1,583
| -1% | -$8.06K | ﹤0.01% | 2504 |
|
|
2013
Q2 | $595K | Buy |
+112,118
| New | +$595K | ﹤0.01% | 2439 |
|